Literature DB >> 21266550

Observing pretibial myxedema in patients with Graves' disease using digital infrared thermal imaging and high-resolution ultrasonography: for better records, early detection, and further investigation.

Shyang-Rong Shih1, Mao-Shin Lin, Hung-Yuan Li, Hsin-Yi Yang, Yung-Lien Hsiao, Met-Ting Chang, Chung-Ming Chen, Tien-Chun Chang.   

Abstract

OBJECTIVE: Pretibial myxedema (PM) is a manifestation of Graves' disease (GD). Currently, its diagnosis depends on physicians' observation and biopsy. No satisfactory, objective, and non-invasive tool is available to record and investigate lesions. Digital infrared thermal imaging (DITI) detects surface temperature, and sonography reflects composition changes in soft tissue. This study was aimed to observe changes in DITI and sonography in PM, and to evaluate their clinical usefulness.
METHODS: Nineteen GD patients with PM, 22 GD patients with mild diffuse non-pitting edema over lower legs, 46 GD patients with normal appearance of lower legs, and 14 normal volunteers were recruited for observation with DITI; 8, 21, 21, and 11 of them respectively also received soft tissue sonography for investigating the pathogenesis of DITI change.
RESULTS: Lower leg temperatures of normal volunteers decreased gradually from proximal to distal parts. In all 19 patients with PM, DITI showed abnormally low focal temperatures over the lesions. In GD patients with mild diffuse non-pitting edema and GD patients with normal appearance of lower legs, DITI showed abnormally low focal temperature in 90.9 and 65.2% of the patients respectively. Areas of clinically visible PM and low focal temperature detected by DITI were sonographically characterized with increased skin thickness, hypoechoic substance deposition in the cutaneous tissue, and blurred boundary lines between dermis and subcutaneous tissue. TSH receptor antibody level correlated positively and significantly with skin thickness change and adjusted temperature difference between the center of temperature defect and the surrounding skin (P=0.046 and 0.033 respectively).
CONCLUSIONS: By using DITI and sonography, we detected characteristic changes in PM. These techniques are helpful in recording and may be useful tools to detect early changes of PM.

Entities:  

Mesh:

Year:  2011        PMID: 21266550     DOI: 10.1530/EJE-10-1095

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Early assessment of the efficacy of digital infrared thermal imaging in pediatric extremity trauma.

Authors:  Cicero T Silva; Nausheen Naveed; Syed Bokhari; Kenneth E Baker; Lawrence H Staib; Saad M Ibrahim; Karl Muchantef; Thomas R Goodman
Journal:  Emerg Radiol       Date:  2012-02-24

Review 2.  Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors:  Luigi Bartalena; Vahab Fatourechi
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

3.  Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases.

Authors:  Changgui Lan; Yi Wang; Xia Zeng; Jing Zhao; Xiaoxi Zou
Journal:  J Thyroid Res       Date:  2016-08-25

4.  Treatment of pretibial myxedema with intralesional immunomodulating therapy.

Authors:  Ziwei Ren; Min He; Fang Deng; Yan Chen; Liyin Chai; Bing Chen; Wuquan Deng
Journal:  Ther Clin Risk Manag       Date:  2017-09-08       Impact factor: 2.423

5.  General hyperpigmentation induced by Grave's disease: A case report.

Authors:  Xiaoxiao Song; Yimin Shen; Ying Zhou; Qinhua Lou; Li Han; Jon Kee Ho; Yuezhong Ren
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves' Disease having Normally Appearing Pretibial Skin: A Case-Control Study.

Authors:  Abhijit Mishra; Partha Pratim Chakraborty; Sayantan Jana; Tarak Nath Saha; Krishnendu Roy
Journal:  Indian J Endocrinol Metab       Date:  2022-06-06

7.  A Randomized Controlled Trial of Intralesional Glucocorticoid for Treating Pretibial Myxedema.

Authors:  Changgui Lan; Can Li; Wei Chen; Xiaofeng Mei; Jing Zhao; Jie Hu
Journal:  J Clin Med Res       Date:  2015-09-25

8.  Local immune microenvironment of skin may play an important role in the development of pretibial myxedema.

Authors:  Xiaoying Chen; Jiaoyun Dong; Li Zhang; Xiaoqing Zhao; Ruofei Shi; Meng Pan; Jie Zheng
Journal:  Exp Dermatol       Date:  2021-06-11       Impact factor: 3.960

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.